ClinicalTrialsFinder

Relapsed Peripheral T-Cell Lymphoma Clinical Trials in Xiamen, Fujian

1 recruitingXiamen, Fujian, China

Showing 1–1 of 1 trials

Recruiting
Phase 2

Chidamide and Duvalisibon for the Treatment of Refractory/Relapsed Peripheral T-cell Lymphoma

Peripheral T Cell LymphomaRelapsed Peripheral T-Cell LymphomaRefractory T-Cell Lymphoma
The First Affiliated Hospital of Xiamen University33 enrolled1 locationNCT06151106